NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Mayo Clinic
CRISPR Therapeutics
Hoffmann-La Roche
HiberCell, Inc.
Intensity Therapeutics, Inc.
Vaccinex Inc.
BeiGene
Federation Francophone de Cancerologie Digestive
Kyowa Kirin Co., Ltd.
Steba Biotech S.A.
MedImmune LLC
Genelux Corporation
Ludwig Institute for Cancer Research
The University of Texas Health Science Center at San Antonio
Vaccinex Inc.
Genocea Biosciences, Inc.
University of California, San Francisco
Eisai Inc.
AVEO Pharmaceuticals, Inc.
Ligand Pharmaceuticals
Pfizer